ANALYZING THE TREATMENT COST OF LIVER CIRRHOSIS FROM HEALTHCARE PAYER'S PERSPECTIVE OF VIETNAM IN 2015

被引：1
|
作者：
Nguyen, D. K. [1 ]
Nguyen, T. T. [2 ]
Pho, N., V [1 ]
机构：
[1] Univ Med & Pharm, Ho Chi Minh City, Vietnam
[2] Univ Med & Pharm HCMC, Ho Chi Minh City, Vietnam
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1429
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI11
引用
收藏
页码：A633 / A633
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
    Borse, Rebekah H.
    Brown, Chloe
    Muszbek, Noemi
    Chaudhary, Mohammad Ashraf
    Kachroo, Sumesh
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 427 - 443
  • [42] Cost-effectiveness of overactive bladder treatments: from the US payer perspective
    Murray, Brian
    Hessami, Sam H.
    Gultyaev, Dmitry
    Lister, Johanna
    Dmochowski, Roger
    Gillard, Kristin Khalaf
    Stanisic, Sanja
    Tung, Amy
    Boer, Robert
    Kaplan, Steven
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 61 - 72
  • [43] Cost of kalium supplementation with Kalipoz prolongatum or kaldyum from payer perspective in Poland
    Kawalec, P
    Glogowski, C
    Krzyzanowska, A
    VALUE IN HEALTH, 2004, 7 (06) : 731 - 731
  • [44] COST-EFFECTIVENESS OF GOLIMUMAB IN PSORIATIC ARTHRITIS FROM THE UK PAYER PERSPECTIVE
    Cummins, E.
    Asseburg, C.
    Prasad, M.
    Buchanan, J.
    Punekar, Y.
    VALUE IN HEALTH, 2010, 13 (07) : A308 - A308
  • [45] Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
    Rebekah H. Borse
    Chloe Brown
    Noemi Muszbek
    Mohammad Ashraf Chaudhary
    Sumesh Kachroo
    Rheumatology and Therapy, 2017, 4 : 427 - 443
  • [46] Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective
    Lumbreras, Ainhoa Gomez
    Tan, Malinda S.
    Villa-Zapata, Lorenzo
    Ilham, Sabrina
    Earl, Jacob C.
    Malone, Daniel C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (06) : 1268 - 1276
  • [47] BUDGET IMPACT MODEL OF HEMOPHILIA A TREATMENT IN TURKEY: A PAYER'S PERSPECTIVE
    Kayadibinli, M.
    Ulus, P.
    Durguner, B.
    VALUE IN HEALTH, 2011, 14 (07) : A412 - A412
  • [48] BUDGET-IMPACT ANALYSIS (BIA) OF OBESITY FROM A HEALTHCARE PAYER PERSPECTIVE IN BRAZIL
    Busch, J.
    Reis Neto, J. P.
    VALUE IN HEALTH, 2019, 22 : S595 - S595
  • [49] Analyzing green building rating tools for healthcare buildings from the building user's perspective
    Kim, Sumin
    Osmond, Paul
    INDOOR AND BUILT ENVIRONMENT, 2014, 23 (05) : 757 - 766
  • [50] COST-EFFECTIVENESS OF FREMANEZUMAB FOR THE TREATMENT OF MIGRAINE IN ENGLAND FROM A HEALTHCARE SYSTEM PERSPECTIVE
    Skroumpelos, A.
    Freddi, M.
    Akcicek, H.
    Cohen, J. M.
    Driessen, M. T.
    VALUE IN HEALTH, 2021, 24 : S160 - S160
12345